DOCSLIB.ORG

JNK and NF‑Κb Signaling Pathways Are Involved in Cytokine Changes in Patients with Congenital Heart Disease Prior to and After Transcatheter Closure

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
JNK and NF‑Κb Signaling Pathways Are Involved in Cytokine Changes in Patients with Congenital Heart Disease Prior to and After Transcatheter Closure EXPERIMENTAL AND THERAPEUTIC MEDICINE 15: 1525-1531, 2018 JNK and NF‑κB signaling pathways are involved in cytokine changes in patients with congenital heart disease prior to and after transcatheter closure SHUNYANG FAN1*, KEFANG LI1*, DEYIN ZHANG2 and FUYUN LIU3 1Heart Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052; 2Department of Internal Medicine, The Third People's Hospital of Henan Province, Zhengzhou, Henan 450000; 3Department of Pediatric Surgery, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China Received December 15, 2016; Accepted August 26, 2017 DOI: 10.3892/etm.2017.5595 Abstract. Congenital heart disease (CHD) is a problem in the changes in cytokines, as well as their recovery following structure of the heart that is present at birth. Due to advances transcatheter closure treatment were associated with the in interventional cardiology, CHD may currently be without JNK and NF-κB signaling pathways. The present study may surgery. The present study aimed to explore the molecular provide further understanding of the underlying molecular mechanism underlying CHD. A total of 200 cases of CHD mechanisms in CHD and propose a potential novel target for treated by transcatheter closure as well as 200 controls were the treatment of CHD. retrospectively assessed. Serum cytokines prior to and after treatment were assessed by reverse-transcription quantitative Introduction polymerase chain reaction analysis. Furthermore, the levels of proteins associated with c-Jun N-terminal kinase (JNK) and Congenital heart disease (CHD), also known as a congenital nuclear factor (NF)-κB were assessed by western blot analysis heart anomaly, is a structural aberration of the heart that and immunohistochemistry. Furthermore, an animal model of exists at birth (1). Its symptoms depend on the specific type CHD in young pigs was successfully constructed and treated of anomaly and therefore symptoms may vary widely, ranging with inhibitors of JNK and/or NF-κB to investigate the roles from none to those of life-threatening severity (2). CHD is of these pathways in CHD. The results revealed that tumor also a major cause of infant mortality worldwide (3). Previous necrosis factor-α, interleukin (IL)‑6 and IL‑8 were significantly studies have demonstrated that 28% of all major congenital elevated in the experimental group following transcatheter anomalies consist of heart defects (4) and the most practical closure treatment, compared with those in the healthy control measurement of CHD occurrence is birth prevalence per group, and the serum levels of the anti‑inflammatory cytokine 1,000 live births (5). The surveillance of birth defects in China IL‑10 were significantly reduced. Phosphorylated c‑Jun and revealed that in 1996 CHD was the 5th most common birth p65 levels in the experimental group were notably higher in the defect and it became the leading birth defect in 2009 (6-8). experimental group compared with the control group, but were At present, CHD is thought to be induced by genetic, life- restored to normal levels following transcatheter closure treat- style and environmental factors, including maternal obesity, ment. Similar results were also obtained in the pig model. The diabetes, toxicant exposure and alterations in anti-oxidant results of the present study suggested that the CHD-associated capacity (9). These well-known risk factors are also associated with immune dysregulation (10). Due to advances in interven- tional cardiology, certain congenital heart anomalies no longer require surgical treatment and are treated via percutaneous interventions (11,12). There have been numerous studies on Correspondence to: Dr Fuyun Liu, Department of Pediatric CHD, however studies reporting on changes of inflamma- Surgery, The Third Affiliated Hospital of Zhengzhou University, tory cytokines in patients with CHD following transcatheter 7 Kangfuqian Road, Zhengzhou, Henan 450052, P.R. China closure treatment are lacking. It has been reported that CHD E-mail: [email protected] patients with a broad spectrum of pathologies demonstrated *Contributed equally certain clinical features and a typical pattern of neurohor- monal activation, which is characteristically found in chronic Key words: congenital heart disease, transcatheter closure, heart failure (CHF) (13). It still remains elusive whether cytokines, animal model, nuclear factor-κB signaling pathway, c-Jun the similarities between adult CHD and CHF extend to the N-terminal kinase signaling pathway inflammatory cytokine system (14). Certain studies reported that tumor necrosis factor (TNF)-α levels were elevated in a small pediatric cohort with CHD (15). However, only few 1526 FAN et al: JNK AND NF-κB IN CONGENITAL HEART DISEASE studies have investigated the level of inflammatory cytokine Table I. Characteristics of patients in the experimental group system activity in CHD patients (16-23). and control group at baseline. Materials and methods Characteristic Experimental group Control group Ethics statement. The present study was approved by the Ethics Sex Committee of the Third Affiliated Hospital of Zhengzhou Male 107 110 University (Zhengzhou, China). Written informed consent was Female 93 90 provided by all subjects. Age (years) 29.6±15.2 25.42±13.28 Height (cm) 172±10.13 175±9.26 Subjects. A total of 200 consecutive patients with CHD Body weight (kg) 65.2±10.15 68.6±14.5 [107 males, 93 females; age, 13‑41 years (29.6±15.2)] admitted to the Third Affiliated Hospital of Zhengzhou Values are expressed as n or as the mean ± standard deviation. University (Zhengzhou, China) between September 2013 and February 2014 were included in this retrospective study. None of the patients had any unassociated abnormalities (not CDH‑specific) or pulmonary hypertension. The cardiac antibody (1:1,000; ab32518), anti‑p‑IΚBα antibody (1:10,000; diagnoses of all patients were made on the basis of clinical (ab133462), anti‑P65 antibody (2.5 µg/ml; ab19870), anti‑p‑P65 and laboratory examinations, including telecardiography, elec- antibody (1:10,000; ab76302) (all from Abcam, Cambridge, trocardiography and echocardiography. The cases treated with MA, USA). This was followed by incubation with the corre- transcatheter closure were retrospectively analyzed. Results sponding horseradish peroxidase-conjugated secondary prior to treatment as well as those at 6 and 12 months were antibodies: anti‑rabbit (ab6721) or anti‑mouse (ab6785) immu- included. Control data were taken from 200 normal individuals noglobulin G antibodies (both 1:5,000; Beyotime Institute of [110 males and 90 females; age, 12‑39 years (25.42±13.28)] Biotechnology, Haimen, China) at 37˚C for 45 min. The target who received a physical examination at the Third Affiliated bands were visualized by using an enhanced chemilumines- Hospital of Zhengzhou University between September 2013 cence kit (Qihai Biotech, Shanghai, China) and the associated and February 2014. band intensities were analyzed using Gel‑Pro‑Analyzer soft- Fasting blood samples were obtained and collected from ware version 4.0 (Media Cybernetics, Inc., Rockville, MD, the antecubital vein using a lightly fitting tourniquet. Blood USA). β-actin was used as the internal control. (3 ml) was drawn from each subject after fasting for 12 h. Samples were collected in a sterile tube and sera were obtained Animal model of CHD. A hybrid method was employed to immediately after clotting of samples, filled in sterile tubes generate the animal model of CHD in young pigs, as previously and stored at ‑80˚C until use. described (26). A total of 50 animals (4‑8 weeks old; 10‑12 kg) were provided by the Third Affiliated Hospital of Zhengzhou Serum biochemical analyses. TNF-α (cat. no. DTA00C), inter- University (Zhengzhou, China), CHD was successfully leukin (IL)-6 (cat. no. D6050), IL-8 (cat. no. DY208) and IL-10 induced in 43 animals and 40 animals were divided into four (cat. no. D1000B) levels were measured using commercially groups (n=10/group) with 3 animals in reserve. All animals available ELISA assay kits (R&D Systems, Minneapolis, MN, were housed in isolated cages under a 12 h light/dark cycle at USA). The results are presented in pg/ml or U/l. 23‑25˚C, humidity 50‑70% with free access to food and water according to the Guide for the Care and Use of Laboratory Reverse‑transcription quantitative polymerase chain reaction Animals (27). A group of 10 normal young pigs was used for (RT‑qPCR) analysis. Total RNA was extracted from the serum determination of serum cytokine levels as a blank control of subjects from the experimental group and the control group group. Over 3 months following surgery, a group of CHD model using an RNA extraction kit (cat. no. DP412; Tiangen Biotech animals with catheter closure treatment received continuous Co., Ltd., Beijing, China) according to the manufacturer's injection of normal saline as a control group. A second group protocol. Detection of the copy number of the mRNA of cyto- of the CHD models received continuous injection of pyrro- kines was performed as previously described (24). lidine dithiocarbamate (PDTC; Sigma‑Aldrich; Merck KGaA, Darmstadt, Germany), a nuclear factor (NF)-κB inhibitor, over Immunohistochemical (IHC) staining. Randomly selected 3 months following catheter closure treatment. Another group samples of peripheral blood mononuclear cells were subjected of CHD models received continuous injection of SP600125 to IHC staining and detection. IHC was performed as previ- (Sigma‑Aldrich; Merck KGaA), a c‑Jun N‑terminal kinase ously described (25). (JNK) inhibitor, and a further group of CHD models received continuous combined injection of PDTC and SP600125 over Western blot analysis. Total protein was extracted and 3 months following catheter closure treatment. All animal quantitated using a BCA Protein Assay reagent (Pierce; protocols were reviewed and approved by the Institutional Thermo Fisher Scientific, Inc., Waltham, MA, USA). Western Animal Care and Use Committee of the Third Affiliated blot analysis was performed as previously described (25). Hospital of Zhengzhou University (Zhengzhou, China).
Load more

Recommended publications
  • Endoplasmic Reticulum–Mitochondria Crosstalk in NIX-Mediated Murine Cell Death Abhinav Diwan Washington University School of Medicine in St
    Washington University School of Medicine Digital Commons@Becker ICTS Faculty Publications Institute of Clinical and Translational Sciences 2009 Endoplasmic reticulum–mitochondria crosstalk in NIX-mediated murine cell death Abhinav Diwan Washington University School of Medicine in St. Louis Scot J. Matkovich Washington University School of Medicine in St. Louis Qunying Yuan University of Cincinnati Wen Zhao University of Cincinnati Atsuko Yatani University of Medicine and Dentistry of New Jersey See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/icts_facpubs Recommended Citation Diwan, Abhinav; Matkovich, Scot J.; Yuan, Qunying; Zhao, Wen; Yatani, Atsuko; Brown, Joan Heller; Molkentin, Jeffery D.; Kranias, Evangelia G.; and Dorn, Gerald W. II, "Endoplasmic reticulum–mitochondria crosstalk in NIX-mediated murine cell death". Journal of Clinical Investigation, 203-212. 2009. Paper 4. https://digitalcommons.wustl.edu/icts_facpubs/4 This Article is brought to you for free and open access by the Institute of Clinical and Translational Sciences at Digital Commons@Becker. It has been accepted for inclusion in ICTS Faculty Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Abhinav Diwan, Scot J. Matkovich, Qunying Yuan, Wen Zhao, Atsuko Yatani, Joan Heller Brown, Jeffery D. Molkentin, Evangelia G. Kranias, and Gerald W. Dorn II This article is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/icts_facpubs/4 Research article Endoplasmic reticulum–mitochondria crosstalk in NIX-mediated murine cell death Abhinav Diwan,1 Scot J. Matkovich,1 Qunying Yuan,2 Wen Zhao,2 Atsuko Yatani,3 Joan Heller Brown,4 Jeffery D.
    [Show full text]
  • Dimerization of Mitophagy Receptor BNIP3L/NIX Is Essential for Recruitment of Autophagic Machinery
    Autophagy ISSN: 1554-8627 (Print) 1554-8635 (Online) Journal homepage: https://www.tandfonline.com/loi/kaup20 Dimerization of mitophagy receptor BNIP3L/NIX is essential for recruitment of autophagic machinery Mija Marinković, Matilda Šprung & Ivana Novak To cite this article: Mija Marinković, Matilda Šprung & Ivana Novak (2020): Dimerization of mitophagy receptor BNIP3L/NIX is essential for recruitment of autophagic machinery, Autophagy, DOI: 10.1080/15548627.2020.1755120 To link to this article: https://doi.org/10.1080/15548627.2020.1755120 View supplementary material Accepted author version posted online: 14 Apr 2020. Published online: 24 Apr 2020. Submit your article to this journal Article views: 69 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=kaup20 AUTOPHAGY https://doi.org/10.1080/15548627.2020.1755120 RESEARCH PAPER Dimerization of mitophagy receptor BNIP3L/NIX is essential for recruitment of autophagic machinery Mija Marinković a, Matilda Šprung b, and Ivana Novak a aSchool of Medicine, University of Split, Split, Croatia; bFaculty of Science, University of Split, Split, Croatia ABSTRACT ARTICLE HISTORY Mitophagy is a conserved intracellular catabolic process responsible for the selective removal of Received 8 August 2019 dysfunctional or superfluous mitochondria to maintain mitochondrial quality and need in cells. Here, Revised 31 March 2020 we examine the mechanisms of receptor-mediated mitophagy activation, with the focus on BNIP3L/NIX Accepted 2 April 2020 mitophagy receptor, proven to be indispensable for selective removal of mitochondria during the KEYWORDS terminal differentiation of reticulocytes. The molecular mechanisms of selecting damaged mitochondria Autophagy; dimerization; from healthy ones are still very obscure.
    [Show full text]
  • Activation of NIX-Mediated Mitophagy by an Interferon Regulatory Factor Homologue of Human Herpesvirus
    ARTICLE https://doi.org/10.1038/s41467-019-11164-2 OPEN Activation of NIX-mediated mitophagy by an interferon regulatory factor homologue of human herpesvirus Mai Tram Vo 1, Barbara J. Smith2, John Nicholas1 & Young Bong Choi 1 Viral control of mitochondrial quality and content has emerged as an important mechanism for counteracting the host response to virus infection. Despite the knowledge of this crucial 1234567890():,; function of some viruses, little is known about how herpesviruses regulate mitochondrial homeostasis during infection. Human herpesvirus 8 (HHV-8) is an oncogenic virus causally related to AIDS-associated malignancies. Here, we show that HHV-8-encoded viral interferon regulatory factor 1 (vIRF-1) promotes mitochondrial clearance by activating mitophagy to support virus replication. Genetic interference with vIRF-1 expression or targeting to the mitochondria inhibits HHV-8 replication-induced mitophagy and leads to an accumulation of mitochondria. Moreover, vIRF-1 binds directly to a mitophagy receptor, NIX, on the mito- chondria and activates NIX-mediated mitophagy to promote mitochondrial clearance. Genetic and pharmacological interruption of vIRF-1/NIX-activated mitophagy inhibits HHV-8 pro- ductive replication. Our findings uncover an essential role of vIRF-1 in mitophagy activation and promotion of HHV-8 lytic replication via this mechanism. 1 Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. 2 Department of Cell Biology, Institute
    [Show full text]
  • BNIP3L/Nix Antibody A
    C 0 2 - t BNIP3L/Nix Antibody a e r o t S Orders: 877-616-CELL (2355) [email protected] Support: 877-678-TECH (8324) 9 8 Web: [email protected] 0 www.cellsignal.com 9 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source: UniProt ID: Entrez-Gene Id: WB, IP H M Endogenous 38, 80 Rabbit O60238 665 Product Usage Information mitochondrial depolarization, generation of reactive oxygen species, and induction of necrosis. Due to its involvement in cell death and autophagy, research scientists have Application Dilution implicated BNIP3L in heart disease and cancer (13). 1. Matsushima, M. et al. (1998) Genes Chromosomes Cancer 21, 230-5. Western Blotting 1:1000 2. Yasuda, M. et al. (1999) Cancer Res 59, 533-7. Immunoprecipitation 1:100 3. Ohi, N. et al. (1999) Cell Death Differ 6, 314-25. 4. Chen, G. et al. (1999) J Biol Chem 274, 7-10. 5. Imazu, T. et al. (1999) Oncogene 18, 4523-9. Storage 6. Schweers, R.L. et al. (2007) Proc Natl Acad Sci USA 104, 19500-5. Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% 7. Sandoval, H. et al. (2008) Nature 454, 232-5. glycerol. Store at –20°C. Do not aliquot the antibody. 8. Aerbajinai, W. et al. (2003) Blood 102, 712-7. 9. Sowter, H.M. et al. (2001) Cancer Res 61, 6669-73. Specificity / Sensitivity 10. Bruick, R.K. (2000) Proc Natl Acad Sci USA 97, 9082-7.
    [Show full text]
  • BNIP3 and NIX Mediate Mieap-Induced Accumulation of Lysosomal Proteins Within Mitochondria
    BNIP3 and NIX Mediate Mieap-Induced Accumulation of Lysosomal Proteins within Mitochondria Yasuyuki Nakamura, Noriaki Kitamura, Daisuke Shinogi, Masaki Yoshida, Olga Goda, Ryuya Murai, Hiroki Kamino, Hirofumi Arakawa* Division of Cancer Biology, National Cancer Center Research Institute, Tokyo, Japan Abstract Mieap, a p53-inducible protein, controls mitochondrial quality by repairing unhealthy mitochondria. During repair, Mieap induces the accumulation of intramitochondrial lysosomal proteins (designated MALM for Mieap-induced accumulation of lysosome-like organelles within mitochondria) by interacting with NIX, leading to the elimination of oxidized mitochondrial proteins. Here, we report that an additional mitochondrial outer membrane protein, BNIP3, is also involved in MALM. BNIP3 interacts with Mieap in a reactive oxygen species (ROS)-dependent manner via the BH3 domain of BNIP3 and the coiled-coil domains of Mieap. The knockdown of endogenous BNIP3 expression severely inhibited MALM. Although the overexpression of either BNIP3 or NIX did not cause a remarkable change in the mitochondrial membrane potential (MMP), the co- expression of all three exogenous proteins, Mieap, BNIP3 and NIX, caused a dramatic reduction in MMP, implying that the physical interaction of Mieap, BNIP3 and NIX at the mitochondrial outer membrane may regulate the opening of a pore in the mitochondrial double membrane. This effect was not related to cell death. These results suggest that two mitochondrial outer membrane proteins, BNIP3 and NIX, mediate MALM in order to maintain mitochondrial integrity. The physical interaction of Mieap, BNIP3 and NIX at the mitochondrial outer membrane may play a critical role in the translocation of lysosomal proteins from the cytoplasm to the mitochondrial matrix.
    [Show full text]
  • Cardiac Reanimation: Targeting Cardiomyocyte Death by BNIP3 and NIX/BNIP3L
    Oncogene (2009) 27, S158–S167 & 2009 Macmillan Publishers Limited All rights reserved 0950-9232/09 $32.00 www.nature.com/onc REVIEW Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3L GW Dorn II1 and LA Kirshenbaum2 1Department of Medicine, Center for Pharmacogenomics, Washington University School of Medicine, St Louis, MO, USA and 2Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada Programmed cardiac myocyte death contributes to are induced in response to cardiac injury or stress, in pathological ventricular remodeling and the progression development of heart failure, and describe the potential of myocardialinfarction or pressure overloadhypertrophy to prevent heart failure by interrupting BNIP3- and to dilated cardiomyopathy. Recent work has identified NIX/BNIP3L-mediated programmed cardiomyocyte importance of stress-mediated transcriptionalinduction of death. BNIP3 (BCL2 and 19-kDa interacting protein-3) and NIX/BNIP3L in cardiac remodeling. Here, the regulatory mechanisms for these two factors in the heart and their effects on programmed cardiomyocyte death are reviewed, Primary or secondary cardiomyocyte loss and the path with a focus on information derived from studies using to heart failure mouse models of cardiac BNIP3 and NIX/BNIP3L overexpression and gene ablation. Heart failure is a clinical syndrome defined as any Oncogene (2009) 27, S158–S167;doi:10.1038/onc.2009.53 condition where the rate of blood delivery to systemic tissues is insufficient to meet their metabolic needs. This Keywords: apoptosis;autophagy;heart failure;cardiac definition includes situations where myocardial function hypertrophy;myocardial infarction is normal and cardiac output (the volume of blood pumped per unit of time, B5 l/min in humans) is within accepted parameters or increased, such as in profound anemia and arteriovenous communications (shunts).
    [Show full text]
  • A Pparγ-Bnip3 Axis Couples Adipose Mitochondrial Fusion-Fission
    Diabetes Volume 65, September 2016 2591 Marc J. Tol,1 Roelof Ottenhoff,1 Marco van Eijk,1,2 Noam Zelcer,1 Jan Aten,3 Sander M. Houten,4,5 Dirk Geerts,6 Cindy van Roomen,1 Marlou C. Bierlaagh,1 Saskia Scheij,1 Marten A. Hoeksema,1 Johannes M. Aerts,2 Jonathan S. Bogan,7 Gerald W. Dorn 2nd,8 Carmen A. Argmann,1,5 and Arthur J. Verhoeven1 A PPARg-Bnip3 Axis Couples Adipose Mitochondrial Fusion-Fission Balance to Systemic Insulin Sensitivity Diabetes 2016;65:2591–2605 | DOI: 10.2337/db16-0243 Aberrant mitochondrial fission plays a pivotal role in outline Bnip3 as a key effector of PPARg-mediated ad- the pathogenesis of skeletal muscle insulin resistance. ipose mitochondrial network fragmentation, improving However, fusion-fission dynamics are physiologically reg- insulin sensitivity and limiting oxidative stress. ulated by inherent tissue-specific and nutrient-sensitive processes that may have distinct or even opposing effects with respect to insulin sensitivity. Based on a Whereas the systemic metabolic benefit ascribed to regu- combination of mouse population genetics and functional lated mitochondrial energy dissipation in beige and brown METABOLISM in vitro assays, we describe here a regulatory circuit fat depots is now widely appreciated (1), the physiological in which peroxisome proliferator–activated receptor g relevance of white adipose tissue (WAT) mitochondria has (PPARg), the adipocyte master regulator and receptor remained enigmatic. By coordinating key biochemical for the thiazolidinedione class of antidiabetic drugs, processes central to WAT, ranging from lipogenesis, glycer- controls mitochondrial network fragmentation through oneogenesis, and adipokine biology, white fat mitochondria transcriptional induction of Bnip3.
    [Show full text]
  • Human Erythroid Differentiation Requires VDAC1-Mediated Mitochondrial Clearance by Martina Moras, Claude Hattab, Pedro Gonzalez-Menendez, Claudio M
    Human erythroid differentiation requires VDAC1-mediated mitochondrial clearance by Martina Moras, Claude Hattab, Pedro Gonzalez-Menendez, Claudio M. Fader, Michael Dussiot, Jerome Larghero, Caroline Le Van Kim, Sandrina Kinet, Naomi Taylor, Sophie D. Lefevre, and Mariano A. Ostuni Haematologica 2020 [Epub ahead of print] Citation: Martina Moras, Claude Hattab, Pedro Gonzalez-Menendez, Claudio M. Fader, Michael Dussiot, Jerome Larghero, Caroline Le Van Kim, Sandrina Kinet, Naomi Taylor, Sophie D. Lefevre, and Mariano A. Ostuni. Human erythroid differentiation requires VDAC1-mediated mitochondrial clearance. Haematologica. 2020; 105:xxx doi:10.3324/haematol.2020.257121 Publisher's Disclaimer. E-publishing ahead of print is increasingly important for the rapid dissemination of science. Haematologica is, therefore, E-publishing PDF files of an early version of manuscripts that have completed a regular peer review and have been accepted for publication. E-publishing of this PDF file has been approved by the authors. After having E-published Ahead of Print, manuscripts will then undergo technical and English editing, typesetting, proof correction and be presented for the authors' final approval; the final version of the manuscript will then appear in print on a regular issue of the journal. All legal disclaimers that apply to the journal also pertain to this production process. Human erythroid differentiation requires VDAC1-mediated mitochondrial clearance Martina Moras1,2,3, Claude Hattab1,2,3, Pedro Gonzalez-Menendez3,4, Claudio M. Fader5,6,
    [Show full text]
  • Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma
    Author Manuscript Published OnlineFirst on September 5, 2019; DOI: 10.1158/0008-5472.CAN-19-0198 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma Jinkyu Jung1,#, Ying Zhang2, Orieta Celiku1, Wei Zhang1, Hua Song1, Brian J. Williams3, Amber J. Giles1, Jeremy N. Rich4, Roger Abounader2, Mark R. Gilbert1, and Deric M. Park1,5,# 1Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA 2Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA 3Department of Neurosurgery, University of Louisville, Louisville, KY, USA 4Department of Medicine, Division of Regenerative Medicine, University of California - San Diego School of Medicine, La Jolla, California, USA 5Neuro-Oncology Section, Department of Neurology, and the Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, USA Abstract word number: 171 Number of figures: 7 Running title: Mitochondrial NIX Maintains Hypoxic Niche of Glioblastoma # Correspondence should be addressed to D.M.P. or J.J. Deric M. Park, M.D. Department of Neurology, The University of Chicago, Chicago, IL 60637 Phone: +1-773-702-3510 Email: [email protected] Jinkyu Jung, Ph.D. Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Phone: +1-301-760-7051 Email: [email protected] Conflict of interest: The authors have declared that no conflict of interest exists. 1 Downloaded from cancerres.aacrjournals.org on September 23, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on September 5, 2019; DOI: 10.1158/0008-5472.CAN-19-0198 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • Loss of Nix in Pdx1-Deficient Mice Prevents Apoptotic and Necrotic β
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2010 Loss of Nix in Pdx1-deficient mice prevents apoptotic and necrotic β cell death and diabetes Kei Fujimoto Washington University School of Medicine in St. Louis Eric L. Ford Washington University School of Medicine in St. Louis Hung Tran Washington University School of Medicine in St. Louis Burton M. Wice Washington University School of Medicine in St. Louis Seth D. Crosby Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Fujimoto, Kei; Ford, Eric L.; Tran, Hung; Wice, Burton M.; Crosby, Seth D.; Dorn, Gerald W. II; and Polonsky, Kenneth S., ,"Loss of Nix in Pdx1-deficient mice prevents apoptotic and necrotic β cell death and diabetes." The ourJ nal of Clinical Investigation.120,11. 4031-4039. (2010). https://digitalcommons.wustl.edu/open_access_pubs/1660 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Kei Fujimoto, Eric L. Ford, Hung Tran, Burton M. Wice, Seth D. Crosby, Gerald W. Dorn II, and Kenneth S. Polonsky This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/1660 Downloaded on September 23, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/44011 Research article Loss of Nix in Pdx1-deficient mice prevents apoptotic and necrotic β cell death and diabetes Kei Fujimoto,1 Eric L.
    [Show full text]
  • Adaptation of Proteasomes and Lysosomes to Cellular Environments
    cells Review Adaptation of Proteasomes and Lysosomes to Cellular Environments Yohannes Afework Mebratu, Zerihun Hailemariam Negasi , Saugata Dutta, Joselyn Rojas-Quintero and Yohannes Tesfaigzi * Pulmonary and Critical Care Medicine Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 01255, USA; [email protected] (Y.A.M.); [email protected] (Z.H.N.); [email protected] (S.D.); [email protected] (J.R.-Q.) * Correspondence: [email protected] Received: 28 August 2020; Accepted: 26 September 2020; Published: 1 October 2020 Abstract: Protein degradation is important for proper cellular physiology as it removes malfunctioning proteins or can provide a source for energy. Proteasomes and lysosomes, through the regulatory particles or adaptor proteins, respectively, recognize proteins destined for degradation. These systems have developed mechanisms to allow adaptation to the everchanging environment of the cell. While the complex recognition of proteins to be degraded is somewhat understood, the mechanisms that help switch the proteasomal regulatory particles or lysosomal adaptor proteins to adjust to the changing landscape of degrons, during infections or inflammation, still need extensive exploration. Therefore, this review is focused on describing the protein degradation systems and the possible sensors that may trigger the rapid adaptation of the protein degradation machinery. Keywords: protein degradation; core particle; regulatory particle; endosome; autophagy; aggresome 1. Background Protein homeostasis or ”proteostasis”, the balance of the synthesis and degradation of proteins, is closely associated with cellular compartments, including the Golgi apparatus, the endoplasmic reticulum (ER), and the lysosome [1]. The ER is not only responsible for the synthesis of the protein backbone, but also for monitoring the quality of the newly synthesized proteins through the unfolded protein response (UPR) system and shuttles misfolded proteins into the degradation pathway.
    [Show full text]
  • Hif1α Or Mitophagy: Which Drives Cardiomyocyte Differentiation?
    News and Thoughts www.cell-stress.com HIF1α or mitophagy: which drives cardiomyocyte differentiation? Beatriz Villarejo-Zori1,#, Juan Ignacio Jiménez-Loygorri1,# and Patricia Boya1,* 1 Department of Cellular and Molecular Biology, Centro de Investigaciones Biológicas Margarita Salas, CSIC, Madrid, Spain. # These authors contributed equally. * Corresponding Author: Patricia Boya, Department of Cellular and Molecular Biology, Centro de Investigaciones Biológicas Margarita Salas, CSIC, Madrid, Spain; E-mail: [email protected] Cardiomyocytes (CMs) are the main cellular component of During heart development, receptor-mediated mitoph- the heart’s atria and ventricles, and their contractile capac- agy is essential for correct mitochondrial network for- ity is the engine that drives blood flow throughout the mation, although the specific details of how mitophagy body. The differentiation of cardiac myoblasts into CMs impacts overall differentiation remain unclear [7]. In this during heart development is an energy-demanding process, issue of Cell Stress, Zhao and collaborators tackle this prob- which is sustained by a metabolic shift towards glycolysis lem in H9c2 cells [8], a widely used in vitro model of CM [1]. Subsequently, differentiated CMs rely almost exclusive- differentiation that can be genetically manipulated to ly on mitochondria-driven oxidative phosphorylation for search for molecular regulators of CM development. When energy production [2]. Metabolic shifts also occur during cultured for 7 days in the presence of low serum and retin- adult CM proliferation in the regenerating heart [3]. In oic acid, these cells express troponin and other CM mark- other contexts, such as neuronal differentiation or immune ers such as MHC. Over this 7-day period of CM differentia- cell activation, cell differentiation is sustained by the up- tion, the authors demonstrate a progressive increase in regulation of glycolysis.
    [Show full text]